BlackRock Fund Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9.88M | Buy |
789,210
+90,435
| +13% | +$1.13M | ﹤0.01% | 2579 |
|
|
2016
Q3 | $9.68M | Buy |
698,775
+40,856
| +6% | +$566K | ﹤0.01% | 2488 |
|
|
2016
Q2 | $6.5M | Buy |
657,919
+51,577
| +9% | +$510K | ﹤0.01% | 2656 |
|
|
2016
Q1 | $10.3M | Buy |
606,342
+17,453
| +3% | +$295K | ﹤0.01% | 2328 |
|
|
2015
Q4 | $13.1M | Buy |
588,889
+275,432
| +88% | +$6.13M | ﹤0.01% | 2293 |
|
|
2015
Q3 | $7.39M | Sell |
313,457
-408
| -0.1% | -$9.62K | ﹤0.01% | 2559 |
|
|
2015
Q2 | $25.7M | Buy |
313,865
+127,173
| +68% | +$10.4M | 0.01% | 1955 |
|
|
2015
Q1 | $17.3M | Buy |
186,692
+12,041
| +7% | +$1.12M | ﹤0.01% | 2141 |
|
|
2014
Q4 | $7.06M | Sell |
174,651
-131,276
| -43% | -$5.31M | ﹤0.01% | 2671 |
|
|
2014
Q3 | $7.48M | Buy |
305,927
+1,300
| +0.4% | +$31.8K | ﹤0.01% | 2523 |
|
|
2014
Q2 | $4.83M | Sell |
304,627
-17,716
| -5% | -$281K | ﹤0.01% | 2857 |
|
|
2014
Q1 | $4.87M | Buy |
322,343
+23,506
| +8% | +$355K | ﹤0.01% | 2833 |
|
|
2013
Q4 | $4.11M | Buy |
298,837
+171,036
| +134% | +$2.35M | ﹤0.01% | 2937 |
|
|
2013
Q3 | $2.41M | Buy |
+127,801
| New | +$2.41M | ﹤0.01% | 3093 |
|